Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 5-year average of -104.66%, near the high end of its 5-year range (-1984.62%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
-132.17%
GROSS MARGIN AVG 5Y
-104.66%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.69%
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Adagio Medical Holdings, Inc.
Market Cap
$3.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-132.17%
5Y Avg
-104.66%
Market Cap
$3.04M
Gross Margin
92.09%
TTM Avg
93.19%
3Y Avg
96.59%
5Y Avg
97.73%
Market Cap
$2.93M
Gross Margin
67.21%
TTM Avg
75.24%
3Y Avg
78.18%
5Y Avg
70.66%
Market Cap
$3.35M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$3.38M
Gross Margin
36.10%
TTM Avg
40.19%
3Y Avg
41.87%
5Y Avg
47.28%
Market Cap
$3.42M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.67M
Gross Margin
23.21%
TTM Avg
29.65%
3Y Avg
45.21%
5Y Avg
30.14%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.12M | 0.00% | 0.00% | -132.17% | -104.66% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | 92.09% | 93.19% | 96.59% | 97.73% |
| Jaguar Health, Inc. (JAGX)vs › | $2.93M | 67.21% | 75.24% | 78.18% | 70.66% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | 0.00% | 0.00% | 25.00% | 50.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.38M | 36.10% | 40.19% | 41.87% | 47.28% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.53M | -6.25% | 25.54% | 36.71% | 34.86% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.67M | 23.21% | 29.65% | 45.21% | 30.14% |
| Eocene Ltd. (EOCN)vs › | $3.78M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.62M | 1.25% | 22.09% | 37.48% | 43.16% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -1011.68% |
| 2024-09-30 | -208.65% |
| 2024-06-30 | -168.50% |
| 2024-03-31 | -1984.62% |
| 2023-12-31 | -328.21% |
| 2023-09-30 | -517.07% |
| 2023-06-30 | -231.40% |
| 2023-03-31 | -430.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
